IMLFF - Dosing underway in InMed Pharma's early-stage INM-755 trial July, 07 2020 09:32 AM InMed Pharmaceuticals Inc. InMed Pharmaceuticals (OTCQX:IMLFF) initiates patient dosing in its second Phase 1 clinical trial with INM-755 ("755-102-HV").More news on: InMed Pharmaceuticals Inc., Healthcare stocks news, Read more ...